84 related articles for article (PubMed ID: 26364410)
1. [Pasireotide as a new second-line treatment option].
Strathaus RS
Med Monatsschr Pharm; 2015 May; 38(5):194-5. PubMed ID: 26364410
[No Abstract] [Full Text] [Related]
2. Medical therapy with somatostatin analogues for acromegaly.
Sassolas G
Eur J Endocrinol; 1995 Dec; 133(6):675-7. PubMed ID: 8548050
[No Abstract] [Full Text] [Related]
3. Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial.
Petersenn S; Schopohl J; Barkan A; Mohideen P; Colao A; Abs R; Buchelt A; Ho YY; Hu K; Farrall AJ; Melmed S; Biller BM;
J Clin Endocrinol Metab; 2010 Jun; 95(6):2781-9. PubMed ID: 20410233
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin analogs in the treatment of acromegaly: the choice is now possible.
Chanson P
Eur J Endocrinol; 2000 Nov; 143(5):573-5. PubMed ID: 11078979
[No Abstract] [Full Text] [Related]
5. Growth-hormone and prolactin excess.
Colao A; Lombardi G
Lancet; 1998 Oct; 352(9138):1455-61. PubMed ID: 9808008
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic value of somatostatin and its analogues.
Farooqi S; Bevan JS; Sheppard MC; Wass JA
Pituitary; 1999 Jun; 2(1):79-88. PubMed ID: 11081176
[TBL] [Abstract][Full Text] [Related]
7. New formulations and approaches in the medical treatment of acromegaly.
Debono M; Newell-Price J
Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):350-5. PubMed ID: 20502324
[TBL] [Abstract][Full Text] [Related]
8. The role of pasireotide in the treatment of acromegaly.
Tritos NA
Lancet Diabetes Endocrinol; 2014 Nov; 2(11):855-6. PubMed ID: 25260837
[No Abstract] [Full Text] [Related]
9. Primary therapy for acromegaly with somatostatin analogs and a discussion of novel peptide analogs.
Kleinberg DL
Rev Endocr Metab Disord; 2005 Jan; 6(1):29-37. PubMed ID: 15711912
[No Abstract] [Full Text] [Related]
10. Emerging drugs for acromegaly.
Störmann S; Schopohl J
Expert Opin Emerg Drugs; 2014 Mar; 19(1):79-97. PubMed ID: 24400774
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy: pasireotide for uncontrolled acromegaly-new phase III trial data.
Sargent J
Nat Rev Endocrinol; 2014 Dec; 10(12):700. PubMed ID: 25311393
[No Abstract] [Full Text] [Related]
12. New insights on SOM230, a universal somatostatin receptor ligand.
Boerlin V; van der Hoek J; Beglinger Ch; Poon KW; Hartmann S; Dutreix C; Kovarik JM; Bruns Ch; Weckbecker G; Lewis I; Schnieper P; Hofland LJ; Lamberts SW
J Endocrinol Invest; 2003; 26(8 Suppl):14-6. PubMed ID: 15233205
[No Abstract] [Full Text] [Related]
13. Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors.
Giustina A; Mazziotti G; Maffezzoni F; Amoroso V; Berruti A
Expert Opin Investig Drugs; 2014 Dec; 23(12):1619-35. PubMed ID: 25060168
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.
N Engl J Med; 1986 May; 314(21):1390-2. PubMed ID: 2871490
[No Abstract] [Full Text] [Related]
15. Use of somatostatin and its long-acting analogue, octreotide, in the treatment of pancreatic diseases.
Delmont J; Hastier P; Dumas R
Aliment Pharmacol Ther; 1995 Oct; 9(5):581-3. PubMed ID: 8580282
[No Abstract] [Full Text] [Related]
16. [Long-term treatment of acromegaly with a somatostatin analog].
Vest S
Ugeskr Laeger; 1987 Aug; 149(34):2263. PubMed ID: 2897734
[No Abstract] [Full Text] [Related]
17. Somatostatin analogs in the treatment of acromegaly.
Lamberts SW; Reubi JC; Krenning EP
Endocrinol Metab Clin North Am; 1992 Sep; 21(3):737-52. PubMed ID: 1355729
[TBL] [Abstract][Full Text] [Related]
18. Pasireotide for the treatment of acromegaly.
Wildemberg LE; Gadelha MR
Expert Opin Pharmacother; 2016; 17(4):579-88. PubMed ID: 26808354
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.
Ma P; Wang Y; van der Hoek J; Nedelman J; Schran H; Tran LL; Lamberts SW
Clin Pharmacol Ther; 2005 Jul; 78(1):69-80. PubMed ID: 16003295
[TBL] [Abstract][Full Text] [Related]
20. [The somatostatin analog: current and future perspectives].
Astorga Jiménez R
Med Clin (Barc); 1989 Oct; 93(13):508-15. PubMed ID: 2576088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
